MiniMed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
16.70
-0.22 (-1.30%)
Jul 21, 2026, 4:00 PM EDT - Market closed

MiniMed Group Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period Ending
Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24
837790737.5737.5724687652652
Revenue Growth (YoY)
15.61%14.99%13.11%13.11%----
Cost of Revenue
357428318.5318.5318292288.5288.5
Gross Profit
480362419419405395364364
Selling, General & Admin
299309287.5287.5276268268268
Research & Development
99114118118107112108.5108.5
Other Operating Expenses
175391212169-7-2.5-2.5
Total Operating Expenses
573462417.5417.5552373374374
Operating Income
-93-1001.51.5-14821-10-10
Total Non-Operating Income (Expense)
1--0.5-0.50---
Pretax Income
-92-9911-14821-10-10
Provision for Income Taxes
931211.511.521281.51.5
Net Income
-185-111-10.5-10.5-168-7-11.5-11.5
Minority Interest in Earnings
08445344
Net Income to Common
-185-119-14.5-14.5-172-10-15.5-15.5
Shares Outstanding (Basic)
268253253253253253--
Shares Outstanding (Diluted)
268253253253253253--
Shares Change (YoY)
6.05%-------
EPS (Basic)
-0.68-0.47-0.06-0.06-0.68-0.04--
EPS (Diluted)
-0.68-0.47-0.06-0.06-0.68-0.04--
Free Cash Flow
-22613-103.5-103.526-26-26.5-26.5
Free Cash Flow Per Share
-0.840.05-0.41-0.410.10-0.10--
Gross Margin
57.35%45.82%56.81%56.81%55.94%57.50%55.83%55.83%
Operating Margin
-11.11%-12.66%0.20%0.20%-20.44%3.06%-1.53%-1.53%
Profit Margin
-22.10%-14.05%-1.42%-1.42%-23.20%-1.02%-1.76%-1.76%
FCF Margin
-27.00%1.65%-14.03%-14.03%3.59%-3.78%-4.06%-4.06%
EBITDA
-54-6140.540.5-110582424
EBITDA Margin
-6.45%-7.72%5.49%5.49%-15.19%8.44%3.68%3.68%
EBIT
-93-1001.51.5-14821-10-10
EBIT Margin
-11.11%-12.66%0.20%0.20%-20.44%3.06%-1.53%-1.53%
Effective Tax Rate
-101.09%-12.12%1150.00%1150.00%-14.19%133.33%-15.00%-15.00%
SEC Filings: 10-K · 10-Q